Discrepant MR and [18F]Fluoroethyl-l-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response criteria based on changes of contrast enhancement (i.e., Macdonald criteria). Furthermore, more precise tumor response assessment criteria (i.e....
Main Authors: | Norbert Galldiks, Christian P. Filss, Roland Goldbrunner, Karl-Josef Langen |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-09-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/342480 |
Similar Items
-
The Semi-automatic Synthesis of 18F-fluoroethyl-choline by Domestic FDG Synthesizer
by: ZHOU Ming, et al.
Published: (2016-02-01) -
Cost-Effectiveness of [18F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma
by: Tristan Baguet, et al.
Published: (2019-08-01) -
Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
by: Yang Z, et al.
Published: (2017-01-01) -
A Fully Automated Radiosynthesis of [18F]Fluoroethyl-Diprenorphine on a Single Module by Use of SPE Cartridges for Preparation of High Quality 2-[18F]Fluoroethyl Tosylate
by: Gjermund Henriksen, et al.
Published: (2013-06-01) -
Synthesis and Biological Evaluation of 3-O-(2-18F-fluoroethyl)-L-DOPA as A Potential PET Agent for Tumor Imaging
by: MA Jingxin1;WU Zhou2;JIANG Shende2;WANG Hongliang1,3;WU Zhifang1,3
Published: (2020-12-01)